TrialAnnals of nuclear medicine2025

Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer.

Xin Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.